THE IMPORTANCE OF SUBSTRATE CONCENTRATION IN DETERMINING CYTOCHROMES P450 THERAPEUTICALLY RELEVANT IN-VIVO

被引：31

作者：

KATO, R

YAMAZOE, Y

机构：

[1] Department of Pharmacology, School of Medicine, Keio University, Shinjuku-ku, Tokyo, 160

来源：

PHARMACOGENETICS | 1994年 / 4卷 / 06期

关键词：

D O I：

10.1097/00008571-199412000-00010

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

[No abstract available]

引用

页码：359 / 362

页数：4

共 24 条

[1] DIAZEPAM METABOLISM BY RAT AND HUMAN LIVER INVITRO - INHIBITION BY MEPHENYTOIN
BEISCHLAG, TV
KALOW, W
MAHON, WA
INABA, T
[J]. XENOBIOTICA, 1992, 22 (05) : 559 - 567
[2] IMPORTANCE OF GENETIC-FACTORS IN THE REGULATION OF DIAZEPAM METABOLISM - RELATIONSHIP TO S-MEPHENYTOIN, BUT NOT DEBRISOQUIN, HYDROXYLATION PHENOTYPE
BERTILSSON, L
HENTHORN, TK
SANZ, E
TYBRING, G
SAWE, J
VILLEN, T
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (04) : 348 - 355
[3] ROLE OF P450IID6, THE TARGET OF THE SPARTEINE-DEBRISOQUIN OXIDATION POLYMORPHISM, IN THE METABOLISM OF IMIPRAMINE
BROSEN, K
ZEUGIN, T
MEYER, UA
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (06) : 609 - 617
[4] HUMAN CYTOCHROME P-450PA (P-450IA2), THE PHENACETIN O-DEETHYLASE, IS PRIMARILY RESPONSIBLE FOR THE HEPATIC 3-DEMETHYLATION OF CAFFEINE AND N-OXIDATION OF CARCINOGENIC ARYLAMINES - (AROMATIC-AMINES HETEROCYCLIC AMINES CARCINOGEN METABOLISM)
BUTLER, MA
IWASAKI, M
GUENGERICH, FP
KADLUBAR, FF
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) : 7696 - 7700
[5] THE ROLE OF S-MEPHENYTOIN 4'-HYDROXYLASE IN IMIPRAMINE METABOLISM BY HUMAN LIVER-MICROSOMES - A 2-ENZYME KINETIC-ANALYSIS OF N-DEMETHYLATION AND 2-HYDROXYLATION
CHIBA, K
SAITOH, A
KOYAMA, E
TANI, M
HAYASHI, M
ISHIZAKI, T
[J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1994, 37 (03) : 237 - 242
[6] DISTLERATH LM, 1985, J BIOL CHEM, V260, P9057
[7] THE GENETIC-POLYMORPHISM OF DEBRISOQUINE SPARTEINE METABOLISM - CLINICAL ASPECTS
EICHELBAUM, M
GROSS, AS
[J]. PHARMACOLOGY & THERAPEUTICS, 1990, 46 (03) : 377 - 394
[8] EVIDENCE FOR INVOLVEMENT OF MULTIPLE FORMS OF CYTOCHROME-P-450 IN AFLATOXIN-B1 METABOLISM IN HUMAN LIVER
FORRESTER, LM
NEAL, GE
JUDAH, DJ
GLANCEY, MJ
WOLF, CR
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (21) : 8306 - 8310
[9] HUMAN CYTOCHROMES-P450 - PROBLEMS AND PROSPECTS
GONZALEZ, FJ
[J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 1992, 13 (09) : 346 - 352
[10] GONZALEZ FJ, 1988, PHARMACOL REV, V40, P243

← 1 2 3 →